Evidence map›Paper›PMID 23449110›Full record

ReviewDiscovery medicine2013

Autoimmunity, end organ damage, and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus.

Janet E Lewis, Shu Man Fu, Felicia Gaskin

Abstract readReview
In one paragraph

Review in Discovery medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.Clinical reviews in allergy & immunology · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. B cells regulate thymic CD8Oncotarget · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Janet E LewisDivision of Rheumatology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
Shu Man Fu
Felicia Gaskin

Funding

Cellular and Genetic Basis of Systemic LupusR01AR047988 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FU, SHU MAN · 2001 to 2020
$8.4M
SPECIALIZED CENTER OF RESEARCH ON SYSTEMIC LUPUS ERYTHEMP50AR045222 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FU, SHU MAN · 1998 to 2006
$7.9M
HLA-D Region Systemic Lupus Erythematosus PathogenesisR01AR049449 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FU, SHU MAN · 2005 to 2015
$4.2M
T Cell Epitope Mimicry for Autoimmune Responses in SLER01AI079621 · NIAID · UNIVERSITY OF VIRGINIA · PI DESHMUKH, UMESH S, FU, SHU MAN · 2009 to 2013
$2.2M
NIAID NIH HHS R01 AI079621NIAID NIH HHS R01-AI079621NIAMS NIH HHS P50- AR04522NIAMS NIH HHS P50 AR045222NIAMS NIH HHS R01 AR047988NIAMS NIH HHS R01-AR047988NIAMS NIH HHS R01 AR049449NIAMS NIH HHS R01-AR049449
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a prototype of systemic autoimmunity affecting many systems. Both antibodies and autoreactive T cells play significant roles in its pathogenesis. Experimental data and clinical observations indicate that autoimmunity and end organ damage are under separate genetic controls and that there are significant interactions between these two pathways. Experimental evidence has been obtained to support the hypothesis that autoantibodies and autoreactive T effector cells may be initiated by environmental factors through molecular mimicry and the inherent polyreactive nature of antigen receptors. A unified hypothesis has been postulated for the pathogenesis of SLE that has practical implications.

Indexed as

Organ SpecificityAutoantibodiesAutoimmunityHumansLupus Erythematosus, SystemicT-LymphocytesAutoantibodies

Identifiers

PMID23449110
PMCPMC3725807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.